- Home
- AIR vs MLTX Comparison
AIR vs MLTX Comparison
Compare AIR & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIR
- MLTX
- Stock Information
- Founded
- AIR 1951
- MLTX 2021
- Country
- AIR United States
- MLTX Switzerland
- Employees
- AIR N/A
- MLTX N/A
- Industry
- AIR Aerospace
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- AIR Industrials
- MLTX Health Care
- Exchange
- AIR Nasdaq
- MLTX Nasdaq
- Market Cap
- AIR 2.6B
- MLTX 2.8B
- IPO Year
- AIR 1988
- MLTX N/A
- Fundamental
- Price
- AIR $76.44
- MLTX $55.07
- Analyst Decision
- AIR Strong Buy
- MLTX Strong Buy
- Analyst Count
- AIR 5
- MLTX 7
- Target Price
- AIR $83.60
- MLTX $73.33
- AVG Volume (30 Days)
- AIR 498.7K
- MLTX 470.6K
- Earning Date
- AIR 07-16-2025
- MLTX 08-06-2025
- Dividend Yield
- AIR N/A
- MLTX N/A
- EPS Growth
- AIR N/A
- MLTX N/A
- EPS
- AIR 0.35
- MLTX N/A
- Revenue
- AIR $2,780,500,000.00
- MLTX N/A
- Revenue This Year
- AIR $3.83
- MLTX $103.42
- Revenue Next Year
- AIR $5.09
- MLTX N/A
- P/E Ratio
- AIR $218.51
- MLTX N/A
- Revenue Growth
- AIR 19.91
- MLTX N/A
- 52 Week Low
- AIR $46.51
- MLTX $31.42
- 52 Week High
- AIR $86.43
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- AIR 56.29
- MLTX 69.45
- Support Level
- AIR $76.42
- MLTX $52.65
- Resistance Level
- AIR $86.43
- MLTX $57.45
- Average True Range (ATR)
- AIR 2.84
- MLTX 2.10
- MACD
- AIR -0.16
- MLTX 0.34
- Stochastic Oscillator
- AIR 42.12
- MLTX 78.52
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in three segments namely Parts Supply, Repair & Engineering, and Integrated Solutions. The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts. Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services. Integrated Solutions segment majorly consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense and foreign governments, flight hour component inventory and repair programs for commercial airlines.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.